Brendan Hannah, Chief Business Officer at Quince Therapeutics, Inc. (QNCX), bought 143,524 shares at $1.22 ($175K) on 2023-08-08, disclosed to the SEC on 2023-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 71,762 | $88K | 50.0% |
| 2 | $1.22 | 71,762 | $88K | 50.0% |
| Total | $1.22 avg | 143,524 | $175K | 100% |